. 2013 Nov 22;105(1):126–133. doi: 10.1111/cas.12305

Table 1.

Correlation between clinicopathological variables and phenotypic mucin marker expression in differentiated-type adenocarcinoma of stomach

Clinicopathological findings	Phenotypic mucin marker expression in tumor cells
	MUC5AC		MUC6		MUC2		CD10
	+/− n = 39/62	P-value	+/− n = 54/47	P-value	+/− n = 22/79	P-value	+/− n = 23/78	P-value
Mean age, years	67.1/70.8	0.056	67.6/71.3	0.054	69.9/69.2	0.772	71.6/68.7	0.205
Gender
Male (n = 78)	31/47	0.668	44/34	0.275	17/61	1.000	20/58	0.206
Female (n = 23)	8/15	0.668	10/13	0.275	5/18	1.000	3/20	0.206
Depth of invasion
T1 (n = 59)	27/32	0.080	41/18	<0.001^*	17/42	0.052	12/47	0.489
T2–4 (n = 42)	12/30	0.080	13/29	<0.001^*	5/37	0.052	11/31	0.489
Lymphatic invasion
Negative (n = 51)	23/28	0.176	36/15	<0.001^*	15/36	0.060	13/38	0.511
Positive (n = 50)	16/34	0.176	18/32	<0.001^*	7/43	0.060	10/40	0.511
Venous invasion
Negative (n = 57)	26/31	0.100	41/16	<0.001^*	17/40	0.030^*	12/45	0.639
Positive (n = 44)	13/31	0.100	13/31	<0.001^*	5/39	0.030^*	11/33	0.639
Mean tumor size, mm	40.8/44.0	0.862	34.6/52.2	0.004^*	37.3/44.3	0.247	42.2/43.0	0.900
Lymph node metastasis
N0 (n = 69)	27/42	0.876	42/27	0.028^*	18/51	0.194	15/54	0.716
N1–3 (n = 32)	12/20	0.876	12/20	0.028^*	4/28	0.194	8/24	0.716
Distant metastasis
M0 (n = 94)	38/56	0.244	52/42	0.246	21/73	1.000	22/72	1.000
M1 (n = 7)	1/6	0.244	2/5	0.246	1/6	1.000	1/6	1.000
Stage
I + II (n = 74)	29/45	0.844	45/29	0.014^*	19/55	0.173	16/58	0.648
III + IV (n = 27)	10/17	0.844	9/18	0.014^*	3/24	0.173	7/20	0.648

P < 0.05 was considered statistically significant. +, positive; −, negative.